1. Home
  2. BGLC vs MRM Comparison

BGLC vs MRM Comparison

Compare BGLC & MRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGLC
  • MRM
  • Stock Information
  • Founded
  • BGLC 2017
  • MRM 2000
  • Country
  • BGLC Malaysia
  • MRM Japan
  • Employees
  • BGLC N/A
  • MRM N/A
  • Industry
  • BGLC Medical Specialities
  • MRM Other Consumer Services
  • Sector
  • BGLC Health Care
  • MRM Consumer Discretionary
  • Exchange
  • BGLC Nasdaq
  • MRM Nasdaq
  • Market Cap
  • BGLC 10.4M
  • MRM 10.4M
  • IPO Year
  • BGLC N/A
  • MRM 2020
  • Fundamental
  • Price
  • BGLC $5.66
  • MRM $1.56
  • Analyst Decision
  • BGLC
  • MRM
  • Analyst Count
  • BGLC 0
  • MRM 0
  • Target Price
  • BGLC N/A
  • MRM N/A
  • AVG Volume (30 Days)
  • BGLC 53.1K
  • MRM 8.0M
  • Earning Date
  • BGLC 08-18-2025
  • MRM 05-20-2025
  • Dividend Yield
  • BGLC N/A
  • MRM N/A
  • EPS Growth
  • BGLC N/A
  • MRM 27.65
  • EPS
  • BGLC N/A
  • MRM 0.18
  • Revenue
  • BGLC $9,551,559.00
  • MRM $52,786,758.00
  • Revenue This Year
  • BGLC N/A
  • MRM N/A
  • Revenue Next Year
  • BGLC N/A
  • MRM N/A
  • P/E Ratio
  • BGLC N/A
  • MRM $9.54
  • Revenue Growth
  • BGLC 4.01
  • MRM 21.55
  • 52 Week Low
  • BGLC $2.01
  • MRM $0.34
  • 52 Week High
  • BGLC $15.60
  • MRM $5.30
  • Technical
  • Relative Strength Index (RSI)
  • BGLC 52.45
  • MRM 43.90
  • Support Level
  • BGLC $5.45
  • MRM $1.67
  • Resistance Level
  • BGLC $5.81
  • MRM $1.97
  • Average True Range (ATR)
  • BGLC 0.20
  • MRM 0.23
  • MACD
  • BGLC -0.02
  • MRM -0.05
  • Stochastic Oscillator
  • BGLC 77.94
  • MRM 2.21

About BGLC BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.

About MRM MEDIROM Healthcare Technologies Inc.

MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.

Share on Social Networks: